A G Thiele1, J F Weigel2, B Ziesch2, C Rohde2, U Mütze2, U Ceglarek3, J Thiery3, A S Müller1, W Kiess2, S Beblo4. 1. Institute of Agricultural and Nutritional Sciences, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. 2. Department of Women and Child Health, Hospital for Children and Adolescents, Centre of Paediatric Research (CPR), University Hospitals, University of Leipzig, Liebigstraße 20 a, D-04103, Leipzig, Germany. 3. Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Leipzig, Germany. 4. Department of Women and Child Health, Hospital for Children and Adolescents, Centre of Paediatric Research (CPR), University Hospitals, University of Leipzig, Liebigstraße 20 a, D-04103, Leipzig, Germany. Skadi.Beblo@medizin.uni-leipzig.de.
Abstract
BACKGROUND: Since 2008 patients with BH(4)-sensitive phenylketonuria can be treated with sapropterin dihydrochloride (Kuvan®) in addition to the classic phenylalanine (Phe) restricted diet. The aim of this study was to evaluate the nutritional changes and micronutrient supply in patients with phenylketonuria (PKU) under therapy with tetrahydrobiopterin (BH(4)). SUBJECTS AND METHODS: 19 children with PKU (4-18 years) and potential BH(4)-sensitivity were included, 14 completed the study protocol. Dried blood Phe concentrations as well as detailed dietary records were obtained throughout the study at preassigned study days. RESULTS: Eight patients could increase their Phe tolerance from 629 ± 476 mg to 2131 ± 1084 mg (P = 0.006) under BH(4) while maintaining good metabolic control (Phe concentration in dried blood 283 ± 145 μM vs. 304 ± 136 μM, P = 1.0), therefore proving to be BH(4)-sensitive. They decreased their consumption of special low protein products and fruit while increasing their consumption of high protein foods such as processed meat, milk and dairy products. Intake of vitamin D (P = 0.016), iron (P = 0.002), calcium (P = 0.017), iodine (P = 0.005) and zinc (P = 0.046) significantly declined during BH(4) treatment while no differences in energy and macronutrient supply occurred. CONCLUSION: BH(4)-sensitive patients showed good metabolic control under markedly increased Phe consumption. However, the insufficient supply of some micronutrients needs consideration. Long-term multicenter settings with higher sample sizes are necessary to investigate the changes of nutrient intake under BH(4) therapy to further evaluate potential risks of malnutrition. Supplementation may become necessary.
BACKGROUND: Since 2008 patients with BH(4)-sensitive phenylketonuria can be treated with sapropterin dihydrochloride (Kuvan®) in addition to the classic phenylalanine (Phe) restricted diet. The aim of this study was to evaluate the nutritional changes and micronutrient supply in patients with phenylketonuria (PKU) under therapy with tetrahydrobiopterin (BH(4)). SUBJECTS AND METHODS: 19 children with PKU (4-18 years) and potential BH(4)-sensitivity were included, 14 completed the study protocol. Dried blood Phe concentrations as well as detailed dietary records were obtained throughout the study at preassigned study days. RESULTS: Eight patients could increase their Phe tolerance from 629 ± 476 mg to 2131 ± 1084 mg (P = 0.006) under BH(4) while maintaining good metabolic control (Phe concentration in dried blood 283 ± 145 μM vs. 304 ± 136 μM, P = 1.0), therefore proving to be BH(4)-sensitive. They decreased their consumption of special low protein products and fruit while increasing their consumption of high protein foods such as processed meat, milk and dairy products. Intake of vitamin D (P = 0.016), iron (P = 0.002), calcium (P = 0.017), iodine (P = 0.005) and zinc (P = 0.046) significantly declined during BH(4) treatment while no differences in energy and macronutrient supply occurred. CONCLUSION:BH(4)-sensitive patients showed good metabolic control under markedly increased Phe consumption. However, the insufficient supply of some micronutrients needs consideration. Long-term multicenter settings with higher sample sizes are necessary to investigate the changes of nutrient intake under BH(4) therapy to further evaluate potential risks of malnutrition. Supplementation may become necessary.
Authors: B Ziesch; J Weigel; A Thiele; U Mütze; C Rohde; U Ceglarek; J Thiery; W Kiess; S Beblo Journal: J Inherit Metab Dis Date: 2012-03-06 Impact factor: 4.982
Authors: B A Stemerdink; A F Kalverboer; J J van der Meere; M W van der Molen; J Huisman; L W de Jong; F M Slijper; P H Verkerk; F J van Spronsen Journal: J Inherit Metab Dis Date: 2000-09 Impact factor: 4.982
Authors: Uta Ceglarek; Peter Müller; Barbara Stach; Peter Bührdel; Joachim Thiery; Wieland Kiess Journal: Clin Chem Lab Med Date: 2002-07 Impact factor: 3.694
Authors: S Kaufman; S Berlow; G K Summer; S Milstien; J D Schulman; S Orloff; S Spielberg; S Pueschel Journal: N Engl J Med Date: 1978-09-28 Impact factor: 91.245
Authors: Ania C Muntau; Wulf Röschinger; Matthias Habich; Hans Demmelmair; Björn Hoffmann; Christian P Sommerhoff; Adelbert A Roscher Journal: N Engl J Med Date: 2002-12-26 Impact factor: 91.245
Authors: Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho Journal: Metab Brain Dis Date: 2013-05-09 Impact factor: 3.584
Authors: C Rohde; A von Teeffelen-Heithoff; A G Thiele; M Arelin; U Mütze; C Kiener; J Gerloff; C Baerwald; S Schultz; C Heller; A S Müller; W Kiess; S Beblo Journal: Eur J Clin Nutr Date: 2013-11-20 Impact factor: 4.016
Authors: A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen Journal: Orphanet J Rare Dis Date: 2017-10-12 Impact factor: 4.123
Authors: Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar Journal: Genet Med Date: 2014-01-02 Impact factor: 8.822
Authors: Hala M Koura; Sherif M Zaki; Nagwa A Ismail; Emad E Salama; Dalia H El Lebedy; Laila K Effat Journal: Iran J Pediatr Date: 2013-12-31 Impact factor: 0.364
Authors: Kimber van Vliet; Iris L Rodenburg; Willem G van Ginkel; Charlotte M A Lubout; Bruce H R Wolffenbuttel; Melanie M van der Klauw; M Rebecca Heiner-Fokkema; Francjan J van Spronsen Journal: Nutrients Date: 2019-08-27 Impact factor: 5.717